CANCERS

Clinical trials for CANCERS explained in plain language.

Never miss a new study

Get alerted when new CANCERS trials appear

Sign up with your email to follow new studies for CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New cancer drug trial halted early: what we know

Disease control Terminated

This early-stage study tested a new drug called NM6603 in 17 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find the safest dose and check for side effects. The trial was ended early, so results are limited.

Matched conditions: CANCERS

Phase: PHASE1 • Sponsor: NucMito Pharmaceuticals Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:30 UTC

CANCERS

Get alerted when new CANCERS trials appear

New cancer drug trial halted early: what we know